Physician

Michael William Lattanzi

According to 2025 Medicare claims, Michael Lattanzi (NPI: 1902255276) practices medical oncology in the Austin-Round Rock-San Marcos, TX market, with the plurality of this provider's patient population coming from Travis, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1972770303; TIN: 752131429) and primary practice location at 78731-4214.

Lattanzi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 573 traditional Medicare patients, billed 155,189 HCPCS/CPT codes, and received $2,797,542 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,040 prescription claims across 143 beneficiaries totaling $785,064 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). Open Payments data shows 143 records totaling $147,084. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,748 to $785,064. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.